The ACTA1 Gene Nemaline Myopathy Type 3 NGS Genetic DNA Test is a crucial diagnostic tool for identifying genetic mutations associated with nemaline myopathy. Priced at 56,000 KSh, this test is essential for patients exhibiting symptoms of muscle weakness and neurological disorders. With a turnaround time of 3 to 4 weeks, patients can receive timely and accurate results, aiding in effective treatment planning.
